EW

Edwards Lifesciences Corporation

HealthcareMedical - DevicesUSUSDPeers →

$86.68

LiveJun 17, 2026

Market cap

$49.91B

52w range

72.30 – 89.60

P / E

—

EPS · FY 2025

$1.83

Volume

4.07M

Revenue · FY 2025

$6.07B

+11.55% YoY

Explain this page

Arphra AIPlain-English read on Edwards Lifesciences Corporation’s valuation

Revenue · 5Y

$6.07B+11.5%

FY21FY22FY23FY24FY25

Net income · 5Y

$1.07B-74.3%

FY21FY22FY23FY24FY25

Margins · FY2025

Gross margin78.1%

Operating margin27.0%

Net margin17.7%

FCF margin22.0%

income_statement_annual

Line item	FY2025	FY2024	FY2023	FY2022	FY2021	YoY
Revenue	6.07B	5.44B	5.01B	5.38B	5.23B	+11.5%
Gross profit	4.74B	4.32B	3.97B	4.22B	4.01B	+9.7%
R&D	1.08B	1.05B	962.9M	945.2M	903.1M	+2.5%
Operating income	1.64B	1.38B	1.43B	1.70B	1.61B	+18.7%
Net income	1.07B	4.17B	1.40B	1.52B	1.50B	-74.3%
Diluted EPS	1.83	6.97	2.30	2.44	2.38	-73.7%
Net margin	17.7%	76.7%	28.0%	28.3%	28.7%	—

Pro

Full income statement, balance sheet, and cash-flow history is included with Pro.